Select country change
Shopping cart (0 , 0,00 ) Menu Search

Scientific References

BioVendor collects scientific publications where the use of our immunoassays, recombinant proteins, and monoclonal and polyclonal antibodies is cited.

Filter references:
  • References to Ferritin Human ELISA

    • Scibior A, Adamczyk A, Golebiowska D, Niedzwiecka I. Effect of 12-week vanadate and magnesium co-administration on chosen haematological parameters as well as on some indices of iron and copper metabolism and biomarkers of oxidative stress in rats. Environ Toxicol Pharmacol. 2012 Sep;34 (2):235-52
    • Stefanova KI, Delcheva GT, Maneva AI, Batalov AZ, Geneva-Popova MG, Karalilova RV, Simitchiev KK. Pathobiochemical Mechanisms Relating Iron Homeostasis to Parameters of Inflammatory Activity and Autoimmune Disorders in Rheumatoid Arthritis. Folia Med (Plovdiv). 2016 Dec 1;58(4):257-263. doi: 10.1515/folmed-2016-0040
  • References to Fetuin-A (AHSG) Human ELISA

    • Abali R, Celik C, Tasdemir N, Guzel S, Alpsoy S, Yuksel A, Celik E. The serum protein alpha2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Bi. 2013 Jul;169 (1):45-9
    • Aleksandrova K, Giuseppe RD, Isermann B, Biemann R, Schulze MB, Wittenbecher C, Fritsche A, Lehmann R, Menzel J, Weikert C, Pischon T, Boeing H. Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC - Potsdam Cohort Study. Cancer Res. 2016 May 23;
    • Argani H, Ghorbanihaghjo A, Panahi G, Rashtchizadeh N, Safa J, Meimand SM. Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients. Clin Biochem. 2012 Jul;45 (10-11):775-9
    • Bakiner O, Bozkirli E, Ertugrul D, Sezgin N, Ertorer E. Plasma fetuin-A levels are reduced in patients with hypothyroidism. Eur J Endocrinol. 2014 Mar;170 (3):411-8
    • Blaha V, Mistrik E, Dusilova-Sulkova S, Kalousova M, Andrys C, Blaha M, Sobotka L. Circulating fetuin-A predicts early mortality in chronic hemodialysis patients. Clin Biochem. 2009 Jul;42 (10-11):996-1000
    • Brettschneider J, Lehmensiek V, Mogel H, Pfeifle M, Dorst J, Hendrich C, Ludolph AC, Tumani H. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neurosci Lett. 2010 Jan 1;468 (1):23-7
    • Briana DD, Boutsikou M, Gourgiotis D, Boutsikou T, Baka S, Marmarinos A, Hassiakos D, Malamitsi-Puchner A. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J Matern Fetal Neonatal Med. 2008 Nov;21 (11):826-30
    • Brix JM, Stingl H, Hollerl F, Schernthaner GH, Kopp HP, Schernthaner G. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab. 2010 Nov;95 (11):4877-81
    • Caglar K, Yilmaz MI, Saglam M, Cakir E, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Vural A, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol. 2008 Jan;3 (1):61-8
    • Caglar K, Yilmaz MI, Saglam M, Cakir E, Kilic S, Sonmez A, Eyileten T, Yenicesu M, Oguz Y, Tasar M, Vural A, Ikizler TA, Stenvinkel P, Lindholm B. Serum fetuin-a concentration and endothelial dysfunction in chronic kidney disease. Nephron Clin Pract. 2008;108 (3):c233-40
    • Cagli K, Basar N, Cagli K, Armutcu F, Aylak F, Yalcinkaya A, Erden G, Kadirogullari E. Association of serum fetuin-A with valvular calcium concentration in rheumatic mitral valve disease. J Heart Valve Dis. 2010 Sep;19 (5):636-43
    • Chang WT, Wu CH, Hsu LW, Chen PW, Yu JR, Chang CS, Tsai WC, Liu PY. Serum vitamin D, intact parathyroid hormone, and Fetuin A concentrations were associated with geriatric sarcopenia and cardiac hypertrophy. Sci Rep. 2017 Jan 23;7:40996. doi: 10.1038/srep40996
    • Cianciolo G, La Manna G, Donati G, Persici E, Dormi A, Cappuccilli ML, Corsini S, Fattori R, Russo V, Nastasi V, Coli L, Wratten M, Stefoni S. Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index?. Blood Purif. 2010;29 (1):13-22
    • Cutler P, Akuffo EL, Bodnar WM, Briggs DM, Davis JB, Debouck CM, Fox SM, Gibson RA, Gormley DA, Holbrook JD, Hunter AJ, Kinsey EE, Prinjha R, Richardson JC, Roses AD, Smith MA, Tsokanas N, Willé DR, Wu W, Yates JW, Gloger IS. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma. Proteomics. 7 Mar 2008;2 Issue 4:467 - 477
    • Dalamaga M, Karmaniolas K, Chamberland J, Nikolaidou A, Lekka A, Dionyssiou-Asteriou A, Mantzoros CS. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. Metabolism. 2013 Dec;62 (12):1830-9
    • Dervisoglu E, Kir HM, Kalender B, Caglayan C, Eraldemir C. Serum fetuin--a concentrations are inversely related to cytokine concentrations in patients with chronic renal failure. Cytokine. 2008 Dec;44 (3):323-7
    • Eller P, Hochegger K, Feuchtner GM, Zitt E, Tancevski I, Ritsch A, Kronenberg F, Rosenkranz AR, Patsch JR, Mayer G. Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure. Nephrol Dial Transplant. 2008 Jan;23 (1):321-7
    • Emoto M, Mori K, Lee E, Kawano N, Yamazaki Y, Tsuchikura S, Morioka T, Koyama H, Shoji T, Inaba M, Nishizawa Y. Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus. Metabolism. 2010 Jun;59 (6):873-8
    • Eraso LH, Ginwala N, Qasim AN, Mehta NN, Dlugash R, Kapoor S, Schwartz S, Schutta M, Iqbal N, Mohler ER 3rd, Reilly MP. Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes. Diabetes Care. 2010 Feb;33 (2):408-10
    • Ford ML, Tomlinson LA, Smith ER, Rajkumar C, Holt SG. Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4. Nephrol Dial Transplant. 2010 Jan 14;
    • Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol. 2010 Nov;21 (11):1998-2007
    • Harris VK, Donelan N, Yan QJ, Clark K, Touray A, Rammal M, Sadiq SA. Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis. Mult Scler. 2013 Oct;19 (11):1462-72
    • Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Haring HU, Stefan N. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One. 2008;3 (3):e1765
    • Hussein NA, Mahmoud OM, Zahran MY, Rafaat MA. Serum Fetuin-A in Chronic Renal Disease Patients: Contribution to Endothelial Dysfunction and Hemostatic alteration. Journal of American Science. 2010;6(12);
    • Hwang JJ, Thakkar B, Chamberland JP, Mantzoros CS. Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration. Metabolism. 2014 Feb 17;
    • Ishibashi A, Ikeda Y, Ohguro T, Kumon Y, Yamanaka S, Takata H, Inoue M, Suehiro T, Terada Y. Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J Atheroscler Thromb. 2010 Sep 30;17 (9):925-33
    • Jimenez MC, Sun Q, Schurks M, Hu FB, Manson JE, Rexrode KM. Circulating fetuin-a and risk of ischemic stroke in women. Clin Chem. 2014 Jan;60 (1):165-73
    • Kaden JJ, Reinohl JO, Blesch B, Brueckmann M, Haghi D, Borggrefe M, Schmitz F, Klomfass S, Pillich M, Ortlepp JR. Systemic and local levels of fetuin-A in calcific aortic valve stenosis. Int J Mol Med. 2007 Aug;20 (2):193-7
    • Kaess BM, Enserro DM, McManus DD, Xanthakis V, Chen MH, Sullivan LM, Ingram C, O'Donnell CJ, Keaney JF, Vasan RS, Glazer NL. Cardiometabolic correlates and heritability of fetuin-a, retinol-binding protein 4, and Fatty-Acid binding protein 4 in the framingham heart study. J Clin Endocrinol Metab. 2012 Oct;97 (10):E1943-7
    • Kamel AA, El-Attar HA, Abaza MM, Gaber EW, Badawi SS. Study of serum osteoprotegerin (OPG), tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and fetuin-A in patients with chronic renal failure. Bull. Alex. Fac. Med. 2007;43 (3)
    • Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B, Duranay M, Akcay A, Armutcu F, Covic A. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol. 2010 Oct;5 (10):1780-6
    • Katayama H, Paczesny S, Prentice R, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J, Rossouw J, Jackson R, Hsia J, Chlebowski R, Manson J, Hanash S. Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Med. 2009;1 (4):47
    • Kaushik SV, Plaisance EP, Kim T, Huang EY, Mahurin AJ, Grandjean PW, Mathews ST. Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. Diabetes Metab Res Rev. 2009 Jul;25 (5):427-34
    • Khadir A, Kavalakatt S, Madhu D, et al. Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation. Lipids Health Dis. 2018;17(1):291. Published 2018 Dec 22. doi:10.1186/s12944-018-0919-x
    • Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, Stumvoll M, Bluher M. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 2010 Sep;299 (3):E506-15
    • Kralisch S, Hoffmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M, Ebert T. Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metabolism. 2017 Mar;68:88-94
    • Kusnierz-Cabala B, Gurda-Duda A, Panek J, Fedak D, Dumnicka P, Solnica B, Kulig J. Serum fetuin A concentrations in patients with acute pancreatitis. Clin Lab. 2010;56 (5-6):191-5
    • Liu X, Hamnvik OP, Chamberland JP, Petrou M, Gong H, Christophi CA, Christiani DC, Kales SN, Mantzoros CS. Circulating alanine transaminase (ALT) and gamma-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: The prospective Cyprus Metabolism Study. Metabolism. 2014 Mar 15;
    • Lorant DP, Grujicic M, Hoebaus C, Brix JM, Hoellerl F, Schernthaner G, Koppensteiner R, Schernthaner GH. Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes Care. 2011 Jan;34 (1):156-61
    • Lorenzen JM, Martino F, Scheffner I, Brocker V, Leitolf H, Haller H, Gwinner W. Fetuin, matrix-gla protein and osteopontin in calcification of renal allografts. PLoS One. 2012;7 (12):e52039
    • Maharem DA, Gomaa SH, El Ghandor MK, Mohamed EI, Matrawy KA, Zaytoun SS, Nomeir HM. Association of serum fetuin-A and fetuin-A gene polymorphism in relation to mineral and bone disorders in patients with chronic kidney disease. Eg. J. Hum. Genet.. September 2013;
    • Mattinzoli D, Ikehata M, Tsugawa K, et al. FGF23 and Fetuin-A Interaction in the Liver and in the Circulation. Int J Biol Sci. 2018;14(6):586-598. Published 2018 Apr 25. doi:10.7150/ijbs.23256
    • McMorrow AM, Connaughton RM, Magalhães TR, et al. Personalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover Trial. Mol Nutr Food Res. 2018;62(10):e1701008.
    • Mori K, Emoto M, Araki T, Yokoyama H, Teramura M, Lee E, Motoyama K, Koyama H, Shoji T, Inaba M, Nishizawa Y. Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf) . Feb;66(2):246-50 (2007)
    • Nascimbeni F, Romagnoli D, Ballestri S, et al. Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?. Diseases. 2018;6(1):17. Published 2018 Feb 16. doi:10.3390/diseases6010017
    • Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, Koyama H, Shoji T, Inaba M, Nishizawa Y. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care . Feb;29(2):468 (2006)
    • Oh S, So R, Shida T, Matsuo T, Kim B, Akiyama K, Isobe T, Okamoto Y, Tanaka K, Shoda J. High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease. Sci Rep. 2017 Feb 22;7:43029. doi: 10.1038/srep43029
    • Oikawa O, Higuchi T, Yamazaki T, Yamamoto C, Fukuda N, Matsumoto K. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. Clin Exp Nephrol. 2007 Dec;11 (4):304-8
    • Ou HY, Lu FH, Wu HT, Hung HC, Wu JS, Yang YC, Chang CJ. Both diabetes and fetuin-A are independently associated with increased risk of arterial stiffness. Clin Chim Acta. 2015 Apr 1;445:133-138
    • Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J Clin Endocrinol Metab. 2012 Dec;97 (12):4717-23
    • Panczyk-Tomaszewska M, Skrzypczyk P, Ziolkowska H, Adamczuk D, Roszkowska-Blaim M. [Fetuin A in children with nephrotic syndrome]. Pol Merkur Lekarski. 2008;24 Suppl 4:65-7
    • Park J, Cha DH, Lee SJ, Kim YN, Kim YH, Kim KP. Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Exp Mol Med. 2011;43(7):427-35.
    • Pertosa G, Simone S, Ciccone M, Porreca S, Zaza G, Dalfino G, Memoli B, Procino A, Bonomini M, Sirolli V, Castellano G, Gesualdo L, Ktena M, Schena FP, Grandaliano G. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?. Am J Kidney Dis. 2009 Mar;53 (3):467-74
    • Petrik V, Saadoun S, Loosemore A, Hobbs J, Opstad KS, Sheldon J, Tarelli E, Howe FA, Bell BA, Papadopoulos MC. Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma. Clin Chem. 2008 Apr;54 (4):713-22
    • Reinehr T, Karges B, Meissner T, Wiegand S, Fritsch M, Holl RW, Woelfle J. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes. J Clin Endocrinol Metab. 2015 Aug;100 (8):3004-10
    • Roos M, Richart T, Kouznetsova T, von Eynatten M, Lutz J, Heemann U, Baumann M, Staessen JA. Fetuin-A and arterial stiffness in patients with normal kidney function. Regul Pept. 2009 Apr 10;154 (1-3):39-43
    • Sak S, Uyanikoglu H, Incebiyik A, et al. Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome. Clin Exp Reprod Med. 2018;45(3):116-121.
    • Sigrist MK, Levin A, Er L, McIntyre CW. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol Dial Transplant. 2009 Oct;24 (10):3157-62
    • Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007 Nov;2 (6):1241-8
    • Smith ER, Cai MM, McMahon LP, Pedagogos E, Toussaint ND, Brumby C, Holt SG. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Nephrology (Carlton). 2013 Mar;18 (3):215-21
    • Smith ER, Ford ML, Tomlinson LA, Rocks BF, Rajkumar C, Holt SG. Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?. Clin Chim Acta. 2010 Sep 6;411 (17-18):1367-70
    • Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, Machicao F, Fritsche A, Haring HU. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care . Apr;29(4):853-7 (2006)
    • Stejskal D, Karpisek M, Vrtal R, Student V, Solichova P, Fiala R, Stejskal P. Urine fetuin-A values in relation to the presence of urolithiasis. BJU Int. 2008 May;101 (9):1151-4
    • Sulkova SD, Kalousova M, Vavrova J, Zima T, Safranek R, Vykoukalova E, Mala A, Pavlikova L, Palicka V. MP576SERUM SOLUBLE ALPHA-KLOTHO CONCENTRATIONS ARE NOT DEPENDENT ON VITAMIN D STATUS IN MAINTENANCE DIALYSIS PATIENTS.
    • Tawfik PH, Hafez SS, Mahmoud NH, El Sayed HM. Serum fetuin A, hs-CRP and homocysteine as biochemical markers of cardiovascular complications in chronic dialysis patients. Acta Med Internat. Jan-Jun 2015;2 (1):57-64
    • Tonjes A, Fasshauer M, Kratzsch J, Stumvoll M, Bluher M. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One. 2010;5 (11):e13911
    • Tseng FY, Chen YT, Chi YC, Chen PL, Yang WS. Serum levels of fetuin-A are negatively associated with log transformation levels of thyroid-stimulating hormone in patients with hyperthyroidism or euthyroidism: An observational study at a medical center in Taiwan. Medicine (Baltimore). 2018;97(46):e13254.
    • Tumani H, Lehmensiek V, Rau D, Guttmann I, Tauscher G, Mogel H, Palm C, Hirt V, Suessmuth SD, Sapunova-Meier I, Ludolph AC, Brettschneider J. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis. Neurosci Lett. 2009 Mar 13;452 (2):214-7
    • Urbanova M, Kalousova M, Zima T, Skibova J, Wohlfahrt P, Viklicky O. Fetuin-A early after renal transplantation. Kidney Blood Press Res. 2009;32 (3):217-22
    • Uz O, Kardesoglu E, Yiginer O, Bas S, Ipcioglu OM, Ozmen N, Aparci M, Cingozbay BY, Isilak Z, Cebeci BS. The relationship between coronary calcification and the metabolic markers of osteopontin, fetuin-A, and visfatin. Turk Kardiyol Dern Ars. 2009 Sep;37 (6):397-402
    • von Jeinsen B, Short MI, Xanthakis V, et al. Association of Circulating Adipokines With Echocardiographic Measures of Cardiac Structure and Function in a Community-Based Cohort. J Am Heart Assoc. 2018;7(13):e008997. Published 2018 Jun 21. doi:10.1161/JAHA.118.008997
    • Wilund KR, Tomayko EJ, Wu PT, Ryong Chung H, Vallurupalli S, Lakshminarayanan B, Fernhall B. Intradialytic exercise training reduces oxidative stress and epicardial fat: a pilot study. Nephrol Dial Transplant. 2010 Aug;25 (8):2695-701
    • Wojtysiak-Duma B, Duma D, Burska A, Janicki K, Zakaszewska K, Skałecki P, Janicka L, Solski J. Fetuin-A in patients undergoing peritoneal dialysis with coronary artery calcification. Annales Universitatis Marie Cu. XXI, N 1, 68, 2008
    • Wu HT, Ou HY, Hung HC, Su YC, Lu FH, Wu JS, Yang YC, Wu CL, Chang CJ. A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes. Diabetologia. 2016 May 25;
    • Yang SJ, Hong HC, Choi HY, Yoo HJ, Cho GJ, Hwang TG, Baik SH, Choi DS, Kim SM, Choi KM. Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women. Clin Endocrinol (Oxf). 2011 Oct;75 (4):464-9
    • Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, Sonmez A, Cakir E, Oguz Y, Vural A, Yenicesu M, Stenvinkel P, Lindholm B, Axelsson J. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol Dial Transplant. 2008 May;23 (5):1621-7
    • Yu CJ, Wang CL, Wang CI, Chen CD, Dan YM, Wu CC, Wu YC, Lee IN, Tsai YH, Chang YS, Yu JS. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology. J Proteome Res. 2011 Oct 7;10 (10):4671-82
    • Zhou ZW, Ju HX, Sun MZ, Fu QP, Chen HM, Ji HB, Ji F, Jiang DM. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy. Clin Chim Acta. 2016 Apr 1;455:113-7
    • Ziolkowska H, Brzewski M, Roszkowska-Blaim M. Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol. 2008 May;23 (5):805-11
    • Ziolkowska H, Wojnar J, Panczyk-Tomaszewska M, Roszkowska-Blaim M. [Fetuin A in children with renal diseases]. Przegl Lek. 2006;63 Suppl 3:54-6
    • Uygun ZO, Şahin Ç, Yılmaz M, Akçay Y, Akdemir A, Sağın F. Fullerene-PAMAM(G5) composite modified impedimetric biosensor to detect Fetuin-A in real blood samples. Anal Biochem. 2018 Feb 1;542:11-15. doi: 10.1016/j.ab.2017.11.007. Epub 2017 Nov 20.
    • Bielesz B, Reiter T, Marculescu R, Gleiss A, Bojic M, Kieweg H, Cejka D. Calcification Propensity of Serum is Independent of Excretory Renal Function. Sci Rep. 2017 Dec 20;7(1):17941. doi: 10.1038/s41598-017-18336-4.
    • Kröger J, Meidtner K, Stefan N, Guevara M, Kerrison ND, Ardanaz E, Aune D, Boeing H, Dorronsoro M, Dow C, Fagherazzi G, Franks PW, Freisling H, Gunter MJ, Huerta JM, Kaaks R, Key TJ, Khaw KT, Krogh V, Kühn T, Mancini FR, Mattiello A, Nilsson PM, Olsen A, Overvad K, Palli D, Quirós JR, Rolandsson O, Sacerdote C, Sala N, Salamanca-Fernández E, Sluijs I, Spijkerman AMW, Tjonneland A, Tsilidis KK, Tumino R, van der Schouw YT, Forouhi NG, Sharp SJ, Langenberg C, Riboli E, Schulze MB, Wareham NJ. Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis. Diabetes. 2018 Jun;67(6):1200-1205. doi: 10.2337/db17-1268.
  • References to Fetuin-A (AHSG) Human, Goat Polyclonal Antibody

    • Fisher E, Stefan N, Saar K, Drogan D, Schulze MB, Fritsche A, Joost HG, Haring HU, Hubner N, Boeing H, Weikert C. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet. 2009 Dec;2 (6):607-13
    • Kröger J, Meidtner K, Stefan N, et al. Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis. Diabetes. 2018;67(6):1200-1205
    • Roos M, Lutz J, Salmhofer H, Luppa P, Knauss A, Braun S, Martinof S, Schomig A, Heemann U, Kastrati A, Hausleiter J. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf). 2008 Apr;68 (4):660-5
    • Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Haring HU, Schulze MB. Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes. Diabetes. 2008 Jul 15;
    • Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Haring HU, Boeing H, Fritsche A. Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke. Circulation. 2008 Nov 24;
  • References to Fetuin-A (AHSG) Human, Rabbit Polyclonal Antibody

    • Ketteler M, Gross ML, Ritz E. Calcification and cardiovascular problems in renal failure. Kidney Int Suppl . Apr;(94):S120-7 (2005)
  • References to Fetuin-B Human ELISA

    • Walker GE, Follenzi A, Bruscaggin V, et al. Fetuin B links vitamin D deficiency and pediatric obesity: Direct negative regulation by vitamin D. J Steroid Biochem Mol Biol. 2018;182:37-49.